Korea United Pharm Inc.
KSC: 033270.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Duk-Young Kang
- Employees
- 936
- Headquarters
- Seoul, South Korea
- IPO year
- 2000
- Market cap
- ₩287.7B
- Website
- https://www.kup.co.kr
Loading 033270…
Loading profile data…Frequently asked questions about 033270
What does Korea United Pharm Inc. (033270.KS) do?
Korea United Pharm Inc. engages in the manufacture and sale of pharmaceutical products in South Korea. It offers products in the areas of respiratory system, musculo-skeletal system, gastro-intestinal tract system, cardiovascular system, anti-cancer, anti-infectives, allergy, immune system, central nervous system, and other diseases, as well OTC...
Where does 033270.KS trade?
Korea United Pharm Inc. (033270.KS) trades on the Korea Exchange.
What sector is 033270.KS in?
Korea United Pharm Inc. (033270.KS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Korea United Pharm Inc.?
Duk-Young Kang is the chief executive officer of Korea United Pharm Inc. (033270.KS).
Where is Korea United Pharm Inc. headquartered?
Korea United Pharm Inc. is headquartered in South Korea.
Does 033270.KS pay a dividend?
Yes — Korea United Pharm Inc. (033270.KS) paid a trailing twelve-month dividend of KRW 610.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 033270.KS go public?
Korea United Pharm Inc. (033270.KS) completed its initial public offering in 2000.